Topics

Journal Club September – A Human Trial of Dasatinib and Quercetin

07:10 EDT 2 Oct 2019 | Life Extension Advocacy Foundation

The topic for the September Edition of the Journal Club was the recent human trial of senolytic agents Dastatinib and Quercetin. For the researchers at the Mayo Clinic this was a follow on study from their previous human trial targeting IPF. This time the researchers ran a study to see how senolytics influenced diabetic kidney...

Original Article: Journal Club September – A Human Trial of Dasatinib and Quercetin

NEXT ARTICLE

More From BioPortfolio on "Journal Club September – A Human Trial of Dasatinib and Quercetin"

Quick Search

Relevant Topic

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...